Skip to main content

Advertisement

Log in

Erythropoietin Protects Rat Brain Injury from Carbon Monoxide Poisoning by Inhibiting Toll-Like Receptor 4/NF-kappa B-Dependent Inflammatory Responses

  • ORIGINAL ARTICLE
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Inflammatory responses play critical roles in carbon monoxide (CO) poisoning-induced cerebral injury. The present study investigated whether erythropoietin (EPO) modulates the toll-like receptor 4 (TLR4) and nuclear factor-kappa B (NF-κB) inflammatory signaling pathways in brain injury after acute CO poisoning. EPO (2500 and 5000 U/kg) was injected subcutaneously twice a day after acute CO poisoning for 2 days. At 48 h after treatment, the expression levels of TLR4 and NF-κB as well as the levels of inflammatory cytokines in the hippocampal tissues were measured. Our results showed that CO poisoning induced a significant upregulation of TLR4, NF-κB, and inflammatory cytokines in the injured rat hippocampal tissues. Treatment with EPO remarkably suppressed the gene and protein expression levels of TLR4 and NF-κB, as well as the concentrations of TNF-α, IL-1β, and IL-6 in the hippocampal tissues. EPO treatment ameliorated CO poisoning-induced histological edema and neuronal necrosis. These results suggested that EPO protected against CO poisoning-induced brain damage by inhibiting the TLR4–NF-κB inflammatory signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Thom, S.R., V.M. Bhopale, D. Fisher, J. Zhang, and P. Gimotty. 2004. Delayed neuropathology after carbon monoxide poisoning is immune-mediated. Proceedings of the National Academy of Sciences of the United States of America 101: 13660–13665.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Wang, W., J. Li, Y. Chang, X. Xie, J. Ren, X. Wang, et al. 2011. Effects of immune reaction in rats after acute carbon monoxide poisoning. Undersea and Hyperbaric Medicine 38: 239–246.

    PubMed  Google Scholar 

  3. Kong, Y., and Y. Le. 2011. Toll-like receptors in inflammation of the central nervous system. International Immunopharmacology 11: 1407–1414.

    Article  CAS  PubMed  Google Scholar 

  4. Kerfoot, S.M., E.M. Long, M.J. Hickey, G. Andonegui, B.M. Lapointe, R.C.O. Zanardo, et al. 2004. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. Journal of Immunology 173: 7070–7077.

    Article  CAS  Google Scholar 

  5. Noelker, C., L. Morel, T. Lescot, A. Osterloh, D. Alvarez-Fischer, M. Breloer, et al. 2013. Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease. Scientific Reports 3: 1393.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hua, F., J. Ma, T. Ha, Y. Xia, J. Kelley, D.L. Williams, et al. 2007. Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. Journal of Neuroimmunology 190: 101–111.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Teng, W., L. Wang, W. Xue, and C. Guan. 2009. Activation of TLR4-mediated NFkappaB signaling in hemorrhagic brain in rats. Mediators of Inflammation 2009: 473276.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ma, C.-x., Yin W-n, Wu.J. Cai B-w, J.-y. Wang, M. He, et al. 2009. Toll-like receptor 4/nuclear factor-kappa B signaling detected in brain after early subarachnoid hemorrhage. Chinese Medical Journal 122: 1575–1581.

    CAS  PubMed  Google Scholar 

  9. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunology 2: 675–680.

    Article  CAS  PubMed  Google Scholar 

  10. Barakat, W., N. Safwet, N.N. El-Maraghy, and M.N.M. Zakaria. 2014. Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade. European Journal of Pharmacology 724: 43–50.

    Article  CAS  PubMed  Google Scholar 

  11. Gassmann, M., K.A. Heinicke, J. Soliz, and O.O. Ogunshola. 2003. Non-erythroid functions of erythropoietin. Hypoxia: Through the Lifecycle 543: 323–330.

    Article  CAS  Google Scholar 

  12. Jelkmann, W., and K. Wagner. 2004. Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Annals of Hematology 83: 673–686.

    Article  CAS  PubMed  Google Scholar 

  13. Agnello, D., P. Bigini, P. Villa, T. Mennini, A. Cerami, M.L. Brines, et al. 2002. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Research 952: 128–134.

    Article  CAS  PubMed  Google Scholar 

  14. Siren, A.-L., T. Fasshauer, C. Bartels, and H. Ehrenreich. 2009. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 6: 108–127.

    Article  CAS  PubMed  Google Scholar 

  15. Pang, L., M. Bian, X.-X. Zang, Y. Wu, D.-H. Xu, N. Dong, et al. 2013. Neuroprotective effects of erythropoietin in patients with carbon monoxide poisoning. Journal of Biochemical and Molecular Toxicology 27: 266–271.

    Article  CAS  PubMed  Google Scholar 

  16. Shahsavand, S., A.H. Mohammadpour, R. Rezaee, E. Behravan, R. Sakhtianchi, and S.A. Moallem. 2012. Effect of erythropoietin on serum brain-derived biomarkers after carbon monoxide poisoning in rats. Iranian Journal of Basic Medical Sciences 15: 752–758.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Wang, Y., Z.G. Zhang, K. Rhodes, M. Renzi, R.L. Zhang, A. Kapke, et al. 2007. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia. British Journal of Pharmacology 151: 1377–1384.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Tietz, N.W., and E.A. Fiereck. 1973. The spectrophotometric measurement of carboxyhemoglobin. Annals of Clinical Laboratory Science 3: 36–42.

    CAS  PubMed  Google Scholar 

  19. Yu, W.H., X.Q. Dong, Y.Y. Hu, M. Huang, Z.Y. Zhang, and B. Ginkgolide. 2012. Reduces neuronal cell apoptosis in the traumatic rat brain: possible involvement of toll-like receptor 4 and nuclear factor kappa B pathway. Phytotherapy Research 26: 1838–1844.

    Article  CAS  PubMed  Google Scholar 

  20. D’Hooge, R., and P.P. De Deyn. 2001. Applications of the Morris water maze in the study of learning and memory. Brain Research Reviews 36: 60–90.

    Article  PubMed  Google Scholar 

  21. Brown, J., H. Wang, G.N. Hajishengallis, and M. Martin. 2011. TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. Journal of Dental Research 90: 417–427.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Lambertsen, K.L., R. Gregersen, M. Meldgaard, B.F.H. Clausen, E.K. Heibol, R. Ladeby, et al. 2004. A role for interferon-gamma in focal cerebral ischemia in mice. Journal of Neuropathology and Experimental Neurology 63: 942–955.

    Article  CAS  PubMed  Google Scholar 

  23. Shichita, T., R. Sakaguchi, M. Suzuki, and A. Yoshimura. 2012. Post-ischemic inflammation in the brain. Frontiers in Immunology 3: 132.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Hyakkoku, K., J. Hamanaka, K. Tsuruma, M. Shimazawa, H. Tanaka, S. Uematsu, et al. 2010. Toll-like receptor 4 (TLR4), but not TLR3 OR TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 171: 258–267.

    Article  CAS  PubMed  Google Scholar 

  25. Ock, J., J. Jeong, W.S. Choi, W.-H. Lee, S.-H. Kim, I.K. Kim, et al. 2007. Regulation of toll-like receptor 4 expression and its signaling by hypoxia in cultured microglia. Journal of Neuroscience Research 85: 1989–1995.

    Article  CAS  PubMed  Google Scholar 

  26. Caso, J.R., J.M. Pradillo, O. Hurtado, P. Lorenzo, M.A. Moro, and I. Lizasoain. 2007. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115: 1599–1608.

    Article  CAS  PubMed  Google Scholar 

  27. Bell, M.T., F. Puskas, V.A. Agoston, J.C. Cleveland Jr., K.A. Freeman, F. Gamboni, et al. 2013. Toll-like receptor 4-dependent microglial activation mediates spinal cord ischemia-reperfusion injury. Circulation 128: S152–S156.

    Article  CAS  PubMed  Google Scholar 

  28. Liu, J., P. Narasimhan, F.S. Yu, and P.H. Chan. 2005. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke 36: 1264–1269.

    Article  CAS  PubMed  Google Scholar 

  29. Dame, C., S.E. Juul, and R.D. Christensen. 2001. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biology of the Neonate 79: 228–235.

    Article  CAS  PubMed  Google Scholar 

  30. Ehrenreich, H., M. Hasselblatt, C. Dembowski, L. Cepek, P. Lewczuk, M. Stiefel, et al. 2002. Erythropoietin therapy for acute stroke is both safe and beneficial. Molecular Medicine 8: 495–505.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Zhu, C., W. Kang, F. Xu, X. Cheng, Z. Zhang, L. Jia, et al. 2009. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 124: E218–E226.

    Article  PubMed  Google Scholar 

  32. Rocchetta, F., S. Solini, M. Mister, C. Mele, P. Cassis, M. Noris, et al. 2011. Erythropoietin enhances immunostimulatory properties of immature dendritic cells. Clinical and Experimental Immunology 165: 202–210.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Wang, X.Y., C.L. Zhu, X.H. Wang, J.G. Gerwien, A. Schrattenholz, M. Sandberg, et al. 2004. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin. Journal of Neurochemistry 91: 900–910.

    Article  CAS  PubMed  Google Scholar 

  34. Omaye, S.T. 2002. Metabolic modulation of carbon monoxide toxicity. Toxicology 180: 139–150.

    Article  CAS  PubMed  Google Scholar 

  35. Prockop, L.D. 2005. Carbon monoxide brain toxicity: clinical, magnetic resonance imaging, magnetic resonance spectroscopy, and neuropsychological effects in 9 people. Journal of Neuroimaging 15: 144–149.

    Article  PubMed  Google Scholar 

  36. Gorman, D., A. Drewry, Y.L. Huang, and C. Sames. 2003. The clinical toxicology of carbon monoxide. Toxicology 187: 25–38.

    Article  CAS  PubMed  Google Scholar 

  37. Xiang, W.-P., H. Xue, and B.-J. Wang. 2014. Delayed encephalopathy of acute carbon monoxide intoxication in rats: potential mechanism and intervention of dexamethasone. Pakistan Journal of Pharmaceutical Sciences 27: 2025–2028.

    CAS  PubMed  Google Scholar 

  38. Thom, S.R., V.M. Bhopale, and D. Fisher. 2006. Hyperbaric oxygen reduces delayed immune-mediated neuropathology in experimental carbon monoxide toxicity. Toxicology and Applied Pharmacology 213: 152–159.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by research grants from the National Natural Science Foundation of China (No. 81501653, No. 81401581) and the Science and Technology Development Plan of Jilin Province (No. 201201042). We thank Medjaden Bioscience Limited for assisting in the preparation of this manuscript.

Authors’ Contributions

Xiang-Wei Meng and Ping Zhang developed the study design and coordinated its implementation, and were responsible for data collection. Li Pang, Ning Dong, and Da-Hai Xu carried out laboratory tests. Nan Zhang and Da-Wei Wang carried out the statistical analysis. Li Pang and Nan Zhang drafted the manuscript. All authors read and approved the final manuscript.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ping Zhang or Xiang-Wei Meng.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Additional information

Li Pang and Nan Zhang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pang, L., Zhang, N., Dong, N. et al. Erythropoietin Protects Rat Brain Injury from Carbon Monoxide Poisoning by Inhibiting Toll-Like Receptor 4/NF-kappa B-Dependent Inflammatory Responses. Inflammation 39, 561–568 (2016). https://doi.org/10.1007/s10753-015-0280-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-015-0280-4

KEY WORDS

Navigation